Enzyvant Therapeutics Inc

Antagen Pharmaceuticals Inc., based in Canton, Massachusetts, is a pioneering biotechnological company committed to developing innovative solutions for pressing healthcare challenges, including infectious diseases, cancer, and autoimmune disorders. With a mission focused on revolutionizing healthcare through advanced research and technology platforms, Antagen is at the forefront of delivering cutting-edge biomedical services and products. Offering a comprehensive array of biotechnological services, Antagen specializes in therapeutic antibody development, recombinant protein production, and the development of COVID-19 detection kits. Their dedication to quality and innovation has garnered positive testimonials from clients who praise the company's expertise and reliability in the industry. Generated from the website

Opexa Therapeutics is a biotechnology company that specializes in the development of patient-specific cellular therapies for the treatment of autoimmune diseases, such as multiple sclerosis and diabetes. It offers Tovaxin, which is a vaccine for early relapsing multiple sclerosis. The company also offers an adult stem cell program that enables the production of multipotent cells generated from patients white blood cells and provides means to differentiate these stem cells into other tissue types. Opexa Therapeutics offers solutions that minimize the threat of treatment rejection. It operates clinical advisory boards for multiple sclerosis and diabetes that take care of the supervision of related procedures. The company provides products to target individual s disease progression and modification.

Lexogen Inc is a biotech company based in Greenland, NH, specializing in RNA and complete transcriptome studies using next generation sequencing technologies. With a focus on being at the forefront of RNA research since 2007, Lexogen's technologies and products are utilized by scientists worldwide. Their QuantSeq Expression Profiling Library Prep Kits offer a cost-efficient alternative to standard RNA-Seq and microarrays, enabling accurate data analysis and the ability to multiplex up to 384 samples in one lane. As pioneers in the field of RNA science, Lexogen combines their expertise with the power of next generation sequencing (NGS) to make significant contributions to the world of genomics. With a commitment to being the word of genes, or the transcriptome, Lexogen strives to provide innovative solutions for researchers and scientists in their pursuit of understanding the complexities of RNA.Generated from the website